Document Detail


Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose.
MedLine Citation:
PMID:  19666952     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The purpose of this study was to investigate the efficacy of landiolol hydrochloride, a short-acting beta(1) blocker, by initiating its administration at a low dose (5 microg kg(-1) min(-1)) in patients with postoperative supraventricular arrhythmia. The efficacy of landiolol was evaluated in 38 patients who, after developing postoperative atrial flutter or fibrillation, with sinus tachycardia and two patients who had a history of paroxysmal atrial fibrillation with frequent atrial extrasystole. The heart rate and blood pressure before and 2 h after the administration of landiolol were compared. A return to the sinus rhythm from supraventricular arrhythmia was noted in 89%. The heart rate was reduced from 137+/-26 bpm (before landiolol administration) to 93+/-18 bpm (2 h after the start of the medication, P<0.01). As an agent to correct an arrhythmic condition, landiolol successfully raised the systolic blood pressure from 108+/-24 mmHg (before medication) to 120+/-19 mmHg (2 h after the medication was started, P<0.05). Continuous intravenous infusion of landiolol at a low dose was found to be effective for postoperative supraventricular arrhythmia.
Authors:
Seiichiro Wariishi; Koichi Yamashita; Hideaki Nishimori; Takashi Fukutomi; Masaki Yamamoto; Geethalakshmi Radhakrishnan; Shiro Sasaguri
Publication Detail:
Type:  Journal Article     Date:  2009-08-10
Journal Detail:
Title:  Interactive cardiovascular and thoracic surgery     Volume:  9     ISSN:  1569-9285     ISO Abbreviation:  Interact Cardiovasc Thorac Surg     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-10-15     Completed Date:  2009-12-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101158399     Medline TA:  Interact Cardiovasc Thorac Surg     Country:  England    
Other Details:
Languages:  eng     Pagination:  811-3     Citation Subset:  IM    
Affiliation:
Department of Surgery II, Kochi University, Kohasu, Nankoku, Kochi, Japan. wari@kochi-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / administration & dosage*
Adult
Aged
Aged, 80 and over
Anti-Arrhythmia Agents / administration & dosage*
Arrhythmias, Cardiac / drug therapy*,  etiology,  physiopathology
Atrial Fibrillation / drug therapy,  etiology
Atrial Flutter / drug therapy,  etiology
Atrial Premature Complexes / drug therapy,  etiology
Blood Pressure / drug effects
Drug Administration Schedule
Female
Heart Rate / drug effects
Humans
Infusions, Intravenous
Male
Middle Aged
Morpholines / administration & dosage*
Postoperative Care
Receptors, Adrenergic, beta-1 / antagonists & inhibitors*
Surgical Procedures, Operative / adverse effects*
Tachycardia, Sinus / drug therapy,  etiology
Time Factors
Treatment Outcome
Urea / administration & dosage,  analogs & derivatives*
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Anti-Arrhythmia Agents; 0/Morpholines; 0/Receptors, Adrenergic, beta-1; 133242-30-5/landiolol; 57-13-6/Urea

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Politicians in apron: case study of rebel health services in Nepal.
Next Document:  Effectiveness of sympathetic block by clipping in the treatment of hyperhidrosis and facial blushing...